In a syngeneic mouse model of prostate cancer, a S100A4 blocking antibody reduced the overall number of intratumor CD3+ T cells while increasing the number of intratumor CD209+ dendritic cells (117). This evidence concerns the gene S100A4 and prostate carcinoma.